Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative bone health optimization with teriparatide versus zoledronic acid in elective spinal fusion
TCTR20260424002Phase 3Not yet recruiting
- Sponsor
- Siriraj Hospital
- Start
- Jun 2026
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of teriparatide, zoledronic acid in osteoporosis, low bone mineral density, Poor bone quality, sponsored by Siriraj Hospital. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
teriparatidezoledronic acid
03
Conditions
osteoporosislow bone mineral densityPoor bone quality
Beyond the preview
Go deeper on TCTR20260424002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260424002.